ODAC Endorses Tamoxifen Trial, With Modification to Ensure Enrollment of Women At Higher Risk
In Brief: Three NCI Basic Science Centers Rank In Index Of Citations; Novello: Help More Smokers Quit
NCI Considering Master Agreements For Cancer Centers
House Passes Bill Authorizing NIH Funds; Veto Likely
NCI Awards Grants To Physicians For Cancer Detection
NCAB Committee To Propose Event Marking Cancer Act
Trending Stories
- Maura Gillison, who identified the role of HPV in head and neck cancer, changing the standard of care, dies at 61
- Johnson and Johnson reaches $5.5B settlement deal over talc lawsuits
- The Directors: New directors Herbst and Gius chart a future built on AI, collaboration, and rural access
- FDA grants Replimune’s RP1 an accelerated approval on third submission after 10:3 vote from advisory committee
Amid political outcry, advisors accept weak data and give sponsor a chance to complete phase III trial - Consumers are increasingly accessing U.S. News rankings of cancer hospitals via AI chatbots
2026 report shows no change in the top-five lineup - What happened at FDA? Replimune approval raises questions









